Sopharma has agreed to acquire Pharmanova, a Serbian-based pharmaceutical company
November 2023 — Sopharma has signed a contract for the phased acquisition of the Serbian-based pharmaceutical manufacturer Pharmanova. The deal is structured in three steps, starting with the acquisition of 25% interest in December 2023, which is increased to 75% in 2024 and to 100% in 2025. With this transaction, Sopharma will further strengthen its market position in the Balkans and add to its family of businesses one of the biggest producers of branded herbal medicines and dietary products in Serbia.
Sopharma is a leading producer and distributor of healthcare products in the CEE region, with a vertically integrated business model running through the whole value chain, having its own R&D, manufacturing, and wholesale and retail distribution. The company is present in 33 countries and has a product portfolio of more than 200 products.
Founded in 1991, Pharmanova manufactures generic and over-the-counter drugs, dietary supplements, ointments and medical devices. It serves the markets of Serbia, Bosnia and Herzegovina, Montenegro and North Macedonia.
Our role in the transaction
Oaklins’ team in Bulgaria acted as the buy-side advisor to Sopharma, leading the transaction process, deal structuring and negotiations, and assisting throughout the course of the acquisition.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreHeka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn more